OpenFilings

Amphastar Pharmaceuticals, Inc.

Form10-Q

Report Period2024-03-31

Date Filed2024-05-10

Time Filed17:50:16

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q
EX-10.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
Filing on SEC Edgar